GlassScriptPhysician profile
Rachel Jimenez
NPI 1215166178
$28,436.45
in general payments reported to CMS, 2019-2025
5 companies · $3,123 in 2025
The $3,123 reported for 2025 was more than what 93% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $25K · 2025: $3,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $6,142 · Honoraria: $1,273 · Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,315.00 |
| Travel and Lodging | $6,141.80 |
| Honoraria | $1,273.00 |
| Food and Beverage | $706.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $24,915.49 | 2024 | |
| Daiichi Sankyo INC. | $1,820.00 | 2025 | Enhertu |
| Iba Proton Therapy, INC. | $1,546.00 | 2024-2025 | |
| Ge Healthcare | $125.00 | 2023 | |
| Incyte Corporation | $29.96 | 2025 | Jakafi, Niktimvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.